BACKGROUND: Clinical stage at the time of diagnosis is the most important determinant of prognosis in cancers of the head and neck. Accordingly, delay in diagnosis could worsen survival in laryngeal cancer, although this hypothesis has not been verified in previous studies. METHODS: To determine the effects of patient and professional diagnostic delays on survival in patients with laryngeal squamous cell carcinoma (LSCC), a population-based sample of 66 patients with LSCC in Northern Finland between 1990 and 1995 was investigated. In addition to clinical data from tertiary care units and mortality data from the national death register, we collected data about the first medical visit in primary care that resulted, subsequently, in the diagnosis of malignancy. RESULTS: Long professional delay in diagnosis (>or=12 months) was an independent and statistically significant determinant of worsened prognosis (adjusted relative hazard of death 4.74, p =.05). There was no correlation between patient delay and prognosis. Another significant factor related to impaired prognosis was advanced stage (IV vs I-III, adjusted relative hazard of death 5.18, p =.02). Long professional delay was not significantly related to any of the demographic or clinical characteristics. CONCLUSIONS: A long professional delay is a marked and independent determinant of impaired survival in laryngeal carcinoma and equals the effect of advanced stage. However, unlike in most other cancers, early symptoms and slow tumor growth give the physician a fairly long time to reach the correct diagnosis before the delay turns out to be fatal. Copyright 2003 Wiley Periodicals, Inc.
BACKGROUND: Clinical stage at the time of diagnosis is the most important determinant of prognosis in cancers of the head and neck. Accordingly, delay in diagnosis could worsen survival in laryngeal cancer, although this hypothesis has not been verified in previous studies. METHODS: To determine the effects of patient and professional diagnostic delays on survival in patients with laryngeal squamous cell carcinoma (LSCC), a population-based sample of 66 patients with LSCC in Northern Finland between 1990 and 1995 was investigated. In addition to clinical data from tertiary care units and mortality data from the national death register, we collected data about the first medical visit in primary care that resulted, subsequently, in the diagnosis of malignancy. RESULTS: Long professional delay in diagnosis (>or=12 months) was an independent and statistically significant determinant of worsened prognosis (adjusted relative hazard of death 4.74, p =.05). There was no correlation between patient delay and prognosis. Another significant factor related to impaired prognosis was advanced stage (IV vs I-III, adjusted relative hazard of death 5.18, p =.02). Long professional delay was not significantly related to any of the demographic or clinical characteristics. CONCLUSIONS: A long professional delay is a marked and independent determinant of impaired survival in laryngeal carcinoma and equals the effect of advanced stage. However, unlike in most other cancers, early symptoms and slow tumor growth give the physician a fairly long time to reach the correct diagnosis before the delay turns out to be fatal. Copyright 2003 Wiley Periodicals, Inc.
Authors: Colin T Murphy; Thomas J Galloway; Elizabeth A Handorf; Brian L Egleston; Lora S Wang; Ranee Mehra; Douglas B Flieder; John A Ridge Journal: J Clin Oncol Date: 2015-11-30 Impact factor: 44.544
Authors: Antonieta Medina-Lara; Bogdan Grigore; Ruth Lewis; Jaime Peters; Sarah Price; Paolo Landa; Sophie Robinson; Richard Neal; William Hamilton; Anne E Spencer Journal: Health Technol Assess Date: 2020-11 Impact factor: 4.014
Authors: Walter J Koskinen; Kjell Brøndbo; Hanna Mellin Dahlstrand; Tapio Luostarinen; Timo Hakulinen; Ilmo Leivo; Anco Molijn; Wim G Quint; Tov Røysland; Eva Munck-Wikland; Antti A Mäkitie; Ilmari Pyykkö; Joakim Dillner; Antti Vaheri; Leena-Maija Aaltonen Journal: J Cancer Res Clin Oncol Date: 2007-05-08 Impact factor: 4.553
Authors: Ho-Sheng Lin; Harvinder S Talwar; Adi L Tarca; Alexei Ionan; Madhumita Chatterjee; Bin Ye; Jerzy Wojciechowski; Saroj Mohapatra; Marc D Basson; George H Yoo; Brian Peshek; Fulvio Lonardo; Chuan-Ju G Pan; Adam J Folbe; Sorin Draghici; Judith Abrams; Michael A Tainsky Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-11 Impact factor: 4.254
Authors: S A R Nouraei; J Philpott; S M Nouraei; D C K Maude; G S Sandhu; A Sandison; P M Clarke Journal: Ann R Coll Surg Engl Date: 2007-03 Impact factor: 1.891
Authors: Maarten A Wildeman; Renske Fles; Camelia Herdini; Rai S Indrasari; Andrew D Vincent; Maesadji Tjokronagoro; Sharon Stoker; Johan Kurnianda; Baris Karakullukcu; Kartika W Taroeno-Hariadi; Olga Hamming-Vrieze; Jaap M Middeldorp; Bambang Hariwiyanto; Sofia M Haryana; I Bing Tan Journal: PLoS One Date: 2013-05-10 Impact factor: 3.240